Cashu
Merck & Co Weighs AI‑Driven Capital Shifts Against R&D Timelines and Manufacturing Constraints
3 days ago
Stocks
Health Care
mrk
Merck & Co
NYSE: MRK
+2.15 (+1.80%)
121.39
USD
At close at Feb 13, 21:34 UTC
Overview
Loading chart...
Key Stats
Market Cap
303.26B
Dividend Yield
0.00%
P/E Ratio
15.93
EPS
6.76
Revenue
64.17B
Avg. Volume
12.49M
About
What does MRK do?
Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.